Consistently, the prognostic value analysis using LOGpc also showed that GC patients with high EDDM3A expression at mRNA level have significant poor overall and recurrence-free survival than those with low EDDM3A expression (Fig. 1G, H). Here, EDDM3A is linked to gastric cancer.